Skip to main content
Figure 5 | BMC Neurology

Figure 5

From: Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1

Figure 5

Reaction times of TAP in patients with NF1 with placebo or lovastatin medication. Data of 10 patients with NF1 are plotted for Alertness, Go/NoGo, Visual Scanning and Incompatibility. For phasic alertness and Incompatibility (KB) patients with NF1 (treated with lovastatin) scored in lower ranges than patients treated with placebo. The significance was set at a level of p < 0.05 and error bars represent ± standard error of the mean. Alertness: –WT (without warning tone), +WT (with warning tone); Visual Scanning: CS (critical stimulus), nCS (non critical stimulus); Incompartibility: CC (critical condition), nCC (non critical condition).

Back to article page